BBH (VanEck Biotech ETF) Stock Analysis - Analyst Ratings

VanEck Biotech ETF (BBH) is a publicly traded the market company. As of May 21, 2026, BBH trades at $144.42 with a market cap of $0 and a P/E ratio of 0.00. BBH moved -1.02% today. Year to date, BBH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BBH?

The average price target is $0.00.

BBH Key Metrics

Key financial metrics for BBH
MetricValue
Price$144.42
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

BBH Analyst Consensus

BBH analyst coverage data. Average price target: $0.00.

Common questions about BBH

What do analysts rate BBH?
The average price target is $0.00.
Does Rallies show BBH price targets?
Yes. Rallies tracks BBH analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBH. It does not provide personalized investment advice.
BBH

BBH